-
The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer’s disease
Das, S., van Engelen, M.-P. E., Goossens, J., Jacobs, D., Bongers, B., Fieldhouse, J. L. P., Pijnenburg, Y. A. L., Teunissen, C. E., Vanmechelen, E. & Verberk, I. M. W., Dec 2024, In: Alzheimer's Research and Therapy. 16, 1, p. 34 34.Research output: Contribution to journal › Article* › Academic › peer-review
-
Cerebrospinal fluid biomarkers and cognitive trajectories in patients with Alzheimer's disease and a history of traumatic brain injury
van Amerongen, S., Das, S., Kamps, S., Goossens, J., Bongers, B., Pijnenburg, Y. A. L., Vanmechelen, E., Vijverberg, E. G. B., Teunissen, C. E. & Verberk, I. M. W., 1 Sept 2024, In: Neurobiology of aging. 141, p. 121-128 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia
Das, S., Goossens, J., Jacobs, D., Dewit, N., Pijnenburg, Y. A. L., in ‘t Veld, S. G. J. G., Teunissen, C. E. & Vanmechelen, E., 1 Dec 2023, In: Alzheimer's Research and Therapy. 15, 1, 62.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
